263 related articles for article (PubMed ID: 22998556)
1. Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.
Goo YA; Cain K; Jarrett M; Smith L; Voss J; Tolentino E; Tsuji J; Tsai YS; Panchaud A; Goodlett DR; Shulman RJ; Heitkemper M
J Proteome Res; 2012 Dec; 11(12):5650-62. PubMed ID: 22998556
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study.
Linsalata M; Riezzo G; D'Attoma B; Clemente C; Orlando A; Russo F
BMC Gastroenterol; 2018 Nov; 18(1):167. PubMed ID: 30400824
[TBL] [Abstract][Full Text] [Related]
3. Identification of serum proteome signature of irritable bowel syndrome: Potential utility of the tool for early diagnosis and patient's stratification.
Tsigaridas A; Anagnostopoulos AK; Papadopoulou A; Ioakeim S; Vaiopoulou A; Papanikolaou IS; Viazis N; Karamanolis G; Mantzaris GJ; Tsangaris GT; Gazouli M
J Proteomics; 2018 Sep; 188():167-172. PubMed ID: 28757466
[TBL] [Abstract][Full Text] [Related]
4. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.
Dunlop SP; Hebden J; Campbell E; Naesdal J; Olbe L; Perkins AC; Spiller RC
Am J Gastroenterol; 2006 Jun; 101(6):1288-94. PubMed ID: 16771951
[TBL] [Abstract][Full Text] [Related]
5. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
[TBL] [Abstract][Full Text] [Related]
6. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
Moskwa A; Chojnacki J; Wiśiewska-Jarosińska M; Stec-Michalska K; Szadkowski K; Smigielski J; Chojnacki C
Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
[TBL] [Abstract][Full Text] [Related]
7. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome.
Hertig VL; Cain KC; Jarrett ME; Burr RL; Heitkemper MM
Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186
[TBL] [Abstract][Full Text] [Related]
8. A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles.
Black CJ; Yiannakou Y; Guthrie EA; West R; Houghton LA; Ford AC
Am J Gastroenterol; 2021 Feb; 116(2):372-381. PubMed ID: 33110014
[TBL] [Abstract][Full Text] [Related]
9. Latent structure of irritable bowel syndrome symptom severity.
Jasper F; Egloff B; Roalfe A; Witthöft M
World J Gastroenterol; 2015 Jan; 21(1):292-300. PubMed ID: 25574104
[TBL] [Abstract][Full Text] [Related]
10. Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome.
Heitkemper MM; Cain KC; Shulman RJ; Burr RL; Ko C; Hollister EB; Callen N; Zia J; Han CJ; Jarrett ME
Benef Microbes; 2018 Apr; 9(3):345-355. PubMed ID: 29633639
[TBL] [Abstract][Full Text] [Related]
11. Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.
Polster A; Van Oudenhove L; Jones M; Öhman L; Törnblom H; Simrén M
Aliment Pharmacol Ther; 2017 Sep; 46(5):529-539. PubMed ID: 28671338
[TBL] [Abstract][Full Text] [Related]
12. Is-it possible to distinguish irritable bowel syndrome with constipation from functional constipation?
Bouchoucha M; Devroede G; Bon C; Bejou B; Mary F; Benamouzig R
Tech Coloproctol; 2017 Feb; 21(2):125-132. PubMed ID: 28066860
[TBL] [Abstract][Full Text] [Related]
13. Nutrient drink test: A promising new tool for irritable bowel syndrome diagnosis.
Estremera-Arevalo F; Barcelo M; Serrano B; Rey E
World J Gastroenterol; 2019 Feb; 25(7):837-847. PubMed ID: 30809083
[TBL] [Abstract][Full Text] [Related]
14. An examination of subgroup classification in irritable bowel syndrome patients over time: a prospective study.
Penny KI; Smith GD; Ramsay D; Steinke DT; Kinnear M; Penman ID
Int J Nurs Stud; 2008 Dec; 45(12):1715-20. PubMed ID: 18829027
[TBL] [Abstract][Full Text] [Related]
15. Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern.
Heitkemper M; Cain KC; Shulman R; Burr R; Poppe A; Jarrett M
Dig Dis Sci; 2011 Jul; 56(7):2050-8. PubMed ID: 21290181
[TBL] [Abstract][Full Text] [Related]
16. Abdominal pain impacts quality of life in women with irritable bowel syndrome.
Cain KC; Headstrom P; Jarrett ME; Motzer SA; Park H; Burr RL; Surawicz CM; Heitkemper MM
Am J Gastroenterol; 2006 Jan; 101(1):124-32. PubMed ID: 16405544
[TBL] [Abstract][Full Text] [Related]
17. Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
Jeffery IB; Das A; O'Herlihy E; Coughlan S; Cisek K; Moore M; Bradley F; Carty T; Pradhan M; Dwibedi C; Shanahan F; O'Toole PW
Gastroenterology; 2020 Mar; 158(4):1016-1028.e8. PubMed ID: 31843589
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.
Du C; Peng L; Kou G; Wang P; Lu L; Li Y
Dig Dis Sci; 2018 May; 63(5):1182-1191. PubMed ID: 29516326
[TBL] [Abstract][Full Text] [Related]
19. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
Lyra A; Rinttilä T; Nikkilä J; Krogius-Kurikka L; Kajander K; Malinen E; Mättö J; Mäkelä L; Palva A
World J Gastroenterol; 2009 Dec; 15(47):5936-45. PubMed ID: 20014457
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
Zhang Y; Qin G; Liu DR; Wang Y; Yao SK
World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
